Donor lymphocyte transfusion for the treatment of Epstein-Barr virus-associated lymphoproliferative disorder of the brain - PubMed (original) (raw)
Case Reports
. 1998 Jun;21(11):1155-8.
doi: 10.1038/sj.bmt.1701205.
Affiliations
- PMID: 9645581
- DOI: 10.1038/sj.bmt.1701205
Case Reports
Donor lymphocyte transfusion for the treatment of Epstein-Barr virus-associated lymphoproliferative disorder of the brain
K Nagafuji et al. Bone Marrow Transplant. 1998 Jun.
Abstract
EBV-associated lymphoproliferative disorder (LPD) is a rare but serious complication in marrow transplant recipients. A 31-year-old Japanese woman in the second chronic phase of CML received an allogeneic BMT from her HLA 2-locus-incompatible 62-year-old father. Around day +200, she developed EBV-LPD of the right parieto-temporal lobe which caused slowly progressive left hemiparesis. Two courses of donor lymphocyte transfusions (DLT) of 10(6)CD3+ T cells/kg of body weight failed to suppress her central nervous system (CNS) EBV-LPD. The patient died of recurrent blastic crisis of CML. This case suggests that DLT may be ineffective for the treatment of CNS EBV-LPD.
Similar articles
- Epstein-Barr virus-associated B cell lymphoproliferative disorder following mismatched related T cell-depleted bone marrow transplantation.
Chiang KY, Hazlett LJ, Godder KT, Abhyankar SH, Christiansen NP, van Rhee F, Lee CG, Bridges K, Parrish RS, Henslee-Downey PJ. Chiang KY, et al. Bone Marrow Transplant. 2001 Dec;28(12):1117-23. doi: 10.1038/sj.bmt.1703311. Bone Marrow Transplant. 2001. PMID: 11803352 - Unsuccessful CTL transfusion in a case of post-BMT Epstein-Barr virus-associated lymphoproliferative disorder (EBV-LPD).
Imashuku S, Goto T, Matsumura T, Naya M, Yamori M, Hojo M, Hibi S, Todo S. Imashuku S, et al. Bone Marrow Transplant. 1997 Aug;20(4):337-40. doi: 10.1038/sj.bmt.1700883. Bone Marrow Transplant. 1997. PMID: 9285550
Cited by
- A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.
Perrine SP, Hermine O, Small T, Suarez F, O'Reilly R, Boulad F, Fingeroth J, Askin M, Levy A, Mentzer SJ, Di Nicola M, Gianni AM, Klein C, Horwitz S, Faller DV. Perrine SP, et al. Blood. 2007 Mar 15;109(6):2571-8. doi: 10.1182/blood-2006-01-024703. Epub 2006 Nov 21. Blood. 2007. PMID: 17119113 Free PMC article. Clinical Trial. - Discrepancy in EBV-DNA load between peripheral blood and cerebrospinal fluid in a patient with isolated CNS post-transplant lymphoproliferative disorder.
Shimizu H, Saitoh T, Koya H, Yuzuriha A, Hoshino T, Hatsumi N, Takada S, Nagaki T, Nojima Y, Sakura T. Shimizu H, et al. Int J Hematol. 2011 Nov;94(5):495-8. doi: 10.1007/s12185-011-0951-3. Epub 2011 Oct 29. Int J Hematol. 2011. PMID: 22038015 - Primary central nervous system post-transplant lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation.
Lieberman F, Yazbeck V, Raptis A, Felgar R, Boyiadzis M. Lieberman F, et al. J Neurooncol. 2012 Apr;107(2):225-32. doi: 10.1007/s11060-011-0739-6. Epub 2011 Oct 26. J Neurooncol. 2012. PMID: 22037801 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials